Smartleaf Asset Management LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 2010393
BOSTON, MA
Position in PTGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$109,096
+$15,290 QoQ
Shares Held
890
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#273
of 341 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Smartleaf Asset Management LLC holds $9,783,497 across 140 Biotechnology names. PTGX ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,540 | $2,255,154 | |
| 2 | CAI |
Caris Life Sciences, Inc.
|
94,051 | $1,675,988 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846 | $527,514 | |
| 4 | ARGX |
Argenx SE
|
463 | $429,557 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,361 | $409,701 | |
| 6 | TECH |
BIO-TECHNE Corp
|
4,639 | $327,745 | |
| 7 | ALLO |
Allogene Therapeutics, Inc.
|
137,874 | $286,777 | |
| 8 | GMAB |
Genmab A/S
|
8,399 | $230,720 |
All Filings in PTGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,096 | 890 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $93,806 | 890 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $150,836 | 1,727 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $93,201 | 1,403 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $69,474 | 1,257 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $58,563 | 1,211 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $19,338 | 501 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $4,050 | 90 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $519 | 15 | Shares | Sole | 2024-10-08 | |
| No filing history on record for this holder in this stock. | ||||||